Domestic pharma manufacturers
Sites aligning SOPs, batch records, and quality systems with Schedule M and WHO TRS expectations before inspections.
- Schedule M
- SMF
- SOP
Industry · Pharma & GMP
Pharmaceutical GMP and COPP readiness
Pharmaceutical manufacturers and exporters use NQSC for WHO-GMP alignment, Site Master File updates, COPP (Certificate of Pharmaceutical Product) applications, and inspection preparation under Indian and WHO frameworks.
- 25+Years Experience
- 500+Companies
- WHO-GMP
- COPP · Schedule M
Pharma & GMP
WHO-GMP · COPP · Dossier
WHO-GMP alignment, COPP applications, and inspection readiness for pharmaceutical manufacturing and export sites in India.
Who we help
Pharma teams we support
Manufacturers and exporters preparing GMP records, COPP files, or inspection readiness.
Export-oriented units
Manufacturers preparing COPP documentation and CDSCO coordination for overseas customer or authority requests.
- COPP
- CPP
- Export
API and formulation sites
Teams updating master files, validation summaries, and change control for multi-product facilities.
- SMF
- Validation
- Change control
Pre-inspection readiness
Organisations closing gaps before WHO-GMP, state FDA, or customer audits with CAPA and training evidence.
- CAPA
- Mock audit
- Training
Regulatory context
GMP and COPP frameworks
Indian pharmaceutical manufacturing is governed by the Drugs and Cosmetics Act with GMP requirements in Schedule M. WHO publishes GMP guidance in Technical Report Series documents used globally.
Schedule M of the Drugs and Cosmetics Rules sets GMP requirements for pharmaceutical manufacturing in India.
Source: CDSCO
WHO Technical Report Series (TRS) documents describe GMP principles adopted in many inspection programmes.
Source: WHO GMP TRS
Certificate of Pharmaceutical Product (COPP/CPP) applications support export of finished dosage forms when importing countries request proof of GMP status.
Source: CDSCO COPP
NQSC services
Services for pharma and GMP
WHO-GMP and audit support pages cover the main NQSC offerings for this sector.
Typical pathway
How teams usually progress
A structured view from scope confirmation through maintenance.
Site and product scope
Define manufacturing lines, products, and target markets for GMP or COPP work.
Gap assessment
Review SMF, SOPs, validation, and records against Schedule M and WHO TRS checkpoints.
Documentation remediation
Update controlled documents, training, and evidence packs for filing or inspection.
COPP or inspection support
Prepare COPP application files and support query responses with CDSCO where applicable.
Post-inspection maintenance
Close CAPA, refresh records, and plan requalification or change control.
Avoid delays
Common mistakes in this sector
Issues NQSC often sees during readiness reviews before filing or audit.
Outdated Site Master File
SMF that does not reflect current layout, equipment, or products triggers inspection findings.
Validation gaps
Missing or expired process, cleaning, or utility validation undermines GMP credibility.
COPP filed before GMP gaps closed
Applications stall when manufacturing records do not support the claimed GMP status.
Weak change control
Undocumented process or supplier changes create traceability problems during audits.
FAQ
Pharma and GMP questions
Inspection roles, COPP timing, and related service pages.
No. NQSC supports documentation and readiness. Regulatory authorities and customers conduct inspections.
Open the WHO-GMP Consultant service page for documents, process, and FAQs on GMP and COPP support.
Yes. Audit and post-approval support can complement WHO-GMP work for CAPA and mock audits.
Scope depends on product type and target market. Share your site layout and product list on consultation.
Discuss pharmaceutical GMP or COPP
Tell us your site status, products, and export needs. NQSC will outline documentation scope.